Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

49
Perinatal Substance Abuse Denice Gardner, MSN, NNP- BC

Transcript of Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Page 1: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Perinatal Substance Abuse

Denice Gardner, MSN, NNP-BC

Page 2: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

• Discuss Perinatal Substance Abuse and its affect on the newborn

Objectives

Page 3: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Pictures used in this presentation were obtained from the Mosby’s Nursing Consult web site

Page 4: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Tobacco/Nicotine Alcohol Stimulants Narcotics & Opioids Sedatives/Hypnotics Antidepressants

Categories of Drugs

Page 5: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Spontaneous abortion Placenta previa Placental abruption Preterm labor Premature rupture of membranes C-Section delivery Precipitous delivery Hypertension

Effects of Drugs on Pregnancy

Page 6: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Tobacco is a CNS stimulant Active components of cigarette smoke

Nicotine Tar Carbon monoxide Cyanide Plus, thousands of other compounds

Tobacco & Nicotine

Page 7: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Nicotine-water & fat soluble; cross the placenta

Carbon Monoxide- combines with hemoglobin & impairs oxygenation for mother & fetus; causes placental vasoconstriction & vasospasm

Dose/Response relationship- the higher the number of cigarettes smoked – the greater the effect on the fetus

Tobacco & Nicotine

Page 8: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Fetal/ Newborn Effects Intrauterine growth restriction Slight increase in risk for congenital

malformations Neurobehavioral effects Sudden Infant Death Syndrome Increased cost of hospitalization &

medical care Increased perinatal mortality

Tobacco & Nicotine

Page 9: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Nursing Considerations EDUCATION Follow infant’s growth Provide information regarding

smoking cessation programs & encourage participation

Tobacco & Nicotine

Page 10: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

CNS depressant Absorbed rapidly through the stomach

& intestines; metabolized by the liver; excreted through the kidneys & lungs

Fetal alcohol is eliminated only after being broken down in the maternal liver

Diffuses across the placenta & impairs flow of nutrients to the fetus

Alcohol

Page 11: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Broken down into acetaldehyde & acetate. (Acetaldehyde is MORE toxic than alcohol).

Is a known teratogen Fetal effects are directly related to

dose, chronicity of use, gestational age, & duration of exposure

Alcohol

Page 12: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Fetal Alcohol Spectrum Disorder (FASD) Fetal Alcohol Syndrome (FAS) Partial Fetal Alcohol Syndrome Alcohol-Related Birth Defects (ARBD) Alcohol-Related Neurodevelopmental

Disorder (ARND)

Alcohol

Page 13: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Most severe form of FASD Most common identifiable cause of

mental retardation (also is a preventable cause)

Abnormalities in 3 domains Poor growth CNS abnormalities (developmental

delays, impaired brain growth, abnormal structure, etc.)

Dysmorphic facial features (thin, upper lip; smooth philtrum; short palpebral fissures, etc.)

Alcohol exposure may or may not be confirmed

Fetal Alcohol Syndrome

Page 14: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Fetal Alcohol Syndrome

Page 15: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Typical dysmorphic facial features Abnormality in one of the domains

CNS abnormality Growth Behavioral or cognitive ability

Confirmed prenatal alcohol exposure

Partial Fetal Alcohol Syndrome

Page 16: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Typical dysmorphic facial features Normal growth and brain

function/structure Congenital anomalies in other organs

(cardiac, skeletal, renal, eyes, ears) Confirmed prenatal alcohol exposure

Alcohol-Related Birth Defects (ARBD)

Page 17: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Absence of typical dysmorphic facial features

Normal Growth CNS abnormalities:

Decreased cranial size at birth Structural brain abnormalities Impairment of neurologic status in

relation to age Behavioral or cognitive abnormalities

inconsistent with age/developmental level

Confirmed prenatal alcohol exposure

Alcohol-Related Neurodevelopmental Disorder

(ARND)

Page 18: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Fetal Alcohol Syndrome

Page 19: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Begins anytime between birth & 12 hours after birth

Symptoms Tremors Hypertonia Opisthotonos Weak suck & poor feeding Sleeplessness Excessive crying Excessive mouthing behavior

Withdrawal from Alcohol

Page 20: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

CocaineAmphetaminesCannabinoids

Stimulants

Page 21: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

One of most powerful addictive substances

Is fat-soluble with low molecular weight so readily crosses blood-brain barrier & placenta

Rarely used alone Long half-life (can be present in

infant’s urine for up to 7 days of age)

Cocaine

Page 22: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Fetal/Newborn Effects No increase in congenital malformations Multi-organ dysfunction

CNS: abnormal sleep pattern, EEG, & cry; seizures/tremors; cerebral infarctions

Sensory organs: increased auditory startle response; abnormal ABR

Cardiac: arrhythmias; hypertension; decreased cardiac output

Cocaine

Page 23: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Fetal/Newborn Effects Multi-organ dysfunction (cont.)

Respiratory: apnea; periodic breathing

Renal: ectopiaGI: intestinal perforation; early-onset

NECEye: vascular, disruptive lesions;

retinal hemorrhage

Cocaine

Page 24: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Felt to be due to CNS irritability from effects of cocaine rather than from withdrawal

Initial period of hyperirritability followed by drowsiness &/or lethargy

Changes in behavioral state Difficulty responding to human

voice/face, comforting, &/or environmental stimuli

Difficulty maintaining alert states or rapid change is states

Hyperactive startle

Withdrawal from Cocaine

Page 25: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Used medically for treatment of narcolepsy, depression, weight loss, hyperactivity

Neurotoxic Fetal/Newborn effects:

IUGR

Amphetamines

Page 26: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Withdrawal from Amphetamines

Abnormal sleep patterns

Diaphoresis Vomiting after birth Agitation alternating

with lethargy Constriction of pupils High-pitched cry

Loose stools Yawning Fever Hyperreflexia

Page 27: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

CNS- both depressant & mild hallucinogenic effects

High affinity for lipids & accumulates in fatty tissue of body

Placental transfer is greatest during first trimester of pregnancy

Results in increased carbon monoxide levels in blood causing hypoxia

Cannabinoids

Page 28: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Natural Opioids Morphine & Opium

Semi-synthetic Opioids Heroin & methadone

Synthetic Opioids Oxycodone, hydromorphone,

oxycodone, Fentanyl, etc.

Narcotics & Opioids

Page 29: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Fetal/Newborn Effects Readily crosses placenta Lower Apgar Scores Do NOT use naloxone for with

known/suspected narcotic & opioid dependence due to creation of rapid withdrawal & seizures

Meconium aspiration IUGR Lower incidence of RDS

Narcotics & Opioids

Page 30: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Congenital infections Increased incidence of SIDS Low birth weight Microcephaly Increased chromosomal

abnormalities in heroine-exposed infants

Narcotics & Opioids

Page 31: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Barbiturates Benzodiazepines

Sedatives/Hypnotics

Page 32: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Readily crosses placenta Fetal blood levels are similar to

maternal blood levels Accumulate in adipose tissue High concentration also present in

brain, lungs, & heart Fetuses exposed to long-term

benzodiazepines may have hypotonia, feeding difficulty, & withdrawal symptoms

Sedative/Hypnotics

Page 33: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Selective Serotonin Reuptake Inhibitors (SSRIs)

Sertaline (Zoloft), Fluoxetine (Prozac), Escitalopram (Lexapro), Paroxetine (Paxil), etc.

Tricyclic Antidepressants (TCAs) Amitriptyline (Elavil), Nortriptyline, etc.

Monoamine Oxidase Inhibitors (MAOIs)

Phenelzine (Nardil), Isocarboxazid (Marplan), etc.

Antidepressants

Page 34: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Onset may vary from shortly after birth to 2 weeks

Duration may range from 8 to 16 weeks Severity of presentation varies Infants of chronic drug abusers usually

have more severe withdrawal The closer to delivery the drug is taken,

the later the signs of withdrawal appear & the more severe the symptoms will be

Neonatal Abstinence Syndrome

Page 35: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Multiorgan/System Disorder Most common symptoms

Neurologic Increased toneTremorsExaggerated reflexes Irritability/restlessnessHigh-pitched cryDifficulty sleepingSeizures

Neonatal Abstinence Syndrome

Page 36: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Most common Symptoms Autonomic

YawningNasal stuffinessSweatingSneezingLow-grade feverMottling

Neonatal Abstinence Syndrome

Page 37: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Most Common Symptoms GI

Loose stoolsVomiting/regurgitationPoor feedingDifficulty swallowingExcessive sucking

Neonatal Abstinence Syndrome

Page 38: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Most Common Symptoms Respiratory

Tachypnea Others

Skin excoriation

Neonatal Abstinence Syndrome

Page 39: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Onset of withdrawal symptoms Alcohol- usually 3-12 hours after delivery Narcotics- usually 48-72 hours after

delivery, but may be as long as 4 weeks Barbiturates- usually 4-7 days after

delivery but can occur 1-14 days after delivery

Cocaine- usually 48-72 hours after delivery

Neonatal Abstinence Syndrome

Page 40: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Severity of NAS depends on The type of drug used Half-life of the drug Time of last exposure before

delivery Dose taken Quality of labor

Neonatal Abstinence Syndrome

Page 41: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Severity of NAS depends on Type of analgesia/anesthesia used

during labor Maturity & status of infant Gestational age Nutritional status of mother

Neonatal Abstinence Syndrome

Page 42: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Scoring Systems Modified Finnegan Scoring Tool

Gold Standard*** Neonatal Drug Withdrawal Scoring

System Neonatal Withdrawal Inventory

Neonatal Abstinence Syndrome

Page 43: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Screening Tools Maternal

Thorough history & assessmentDrug testing (urine is most

commonly used) Infant

Thorough assessmentUrine Drug screenMeconium Drug ScreenNewer testing: hair and umbilical

cord testing

Neonatal Abstinence Syndrome

Page 44: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Nursing Management Accurate assessment, evaluation, &

use if institution’s screening tool Comfort measures (swaddling, holding,

cuddling, response to stress cues, etc.) Assessment & encouragement of

mother/infant interaction Maternal/family support

Neonatal Abstinence Syndrome

Page 45: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Pharmacologic management Tincture of opium Camphorated Tincture of Opium

(Paregoric) Morphine (most common) Methadone Clonidine Chlorpromazine (Thorazine) Phenobarbital Diazepam

Neonatal Abstinence Syndrome

Page 46: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Breastfeeding Cigarettes:

not contraindicated encourage decreasing numbers of cigarettes smoked & smoking cessation

Smoke after breast feeding Alcohol: use should be discouraged

Neonatal Abstinence Syndrome

Page 47: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Breastfeeding Cocaine: contraindicated during

active use Marijuana: contraindicated Heroin: contraindicated Methadone: not contraindicated;

should not be stopped abruptly Sedatives/Hypnotics: dose-

dependent; discontinue with signs of lethargy &/or weight loss

Neonatal Abstinence Syndrome

Page 48: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Chang, G., Lockwood, C.J., & Barss. (2012). Substance Use In Pregnancy. Retrieved from www.uptodate.com on 8/17/2012.Sielski, L.A., Garcia-Prats, J.A., & Kim, M.S. (2012). Infants of Mothers with Substance Abuse. Retrieved from

www.uptodate.com on 8/17/2012.

References

Page 49: Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.

Sielski, L.A., Garcia-Prats, J.A., & Kim, M.S. (2012). Neonatal Opioid Withdrawal

(Neonatal Abstinence Syndrome). `Retrieved from www.uptodate.com on 8/17/2012.

Verklan, M.T. & Walden, M. (2009). Core Curriculum for Neonatal Intensive Care Nursing (4rd Edition). Elseiver Saunders: St. Louis. Retrieved from Mosby’s Nursing

Consult web site on 6/16/2012.

References